We are live on ! Find out more
ALDR

Alder Biopharmaceuticals
ALDR

Delisted

ALDR was delisted on the 21st of October, 2019.

Back to rankings

0 hedge funds and large institutions have $0 invested in Alder Biopharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 143 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 143 → 0 (-143)

100% less funds holding in top 10

Funds holding in top 10: 8 → 0 (-8)

100% less capital invested

Capital invested by funds: $1.75B → $0 (-$1.75B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 143

Holders
–
Holders Change
-143
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-8
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
143
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
RG
Redmile Group
California
-$155M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$123M
3
BlackRock
BlackRock
New York
-$120M
4
BG
Bellevue Group
Switzerland
-$84.7M
5
FCM
Farallon Capital Management
California
-$78.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
AIP
126
Ameritas Investment Partners
Nebraska
– -$118K -6,241 Closed
Public Employees Retirement Association of Colorado
127
Public Employees Retirement Association of Colorado
Colorado
– -$115K -6,115 Closed
Zurich Cantonal Bank
128
Zurich Cantonal Bank
Switzerland
– -$73K -3,877 Closed
PCM
129
Prelude Capital Management
New York
– -$55K -2,914 Closed
LTFS
130
Ladenburg Thalmann Financial Services
Florida
– -$54K -2,866 Closed
Canada Life
131
Canada Life
Manitoba, Canada
– -$39K -2,085 Closed
CG
132
Cutler Group
California
– -$28K -1,500 Closed
US Bancorp
133
US Bancorp
Minnesota
– -$19K -1,000 Closed
AG
134
Advisor Group
Arizona
– -$18K -950 Closed
GT
135
Glenmede Trust
Pennsylvania
– -$14 -812 Closed
Nisa Investment Advisors
136
Nisa Investment Advisors
Missouri
– -$13K -700 Closed
IUHSA
137
Itau Unibanco Holding S.A.
Brazil
– -$7K -618 Closed
Daiwa Securities Group
138
Daiwa Securities Group
Japan
– -$10K -533 Closed
SIAS
139
Shine Investment Advisory Services
Colorado
– -$9K -490 Closed
LJHT
140
Laurie J. Hall Trustee
– -$7K -360 Closed
QT
141
Quantbot Technologies
New York
– -$5K -300 Closed
WT
142
Whittier Trust
California
– -$5K -271 Closed
GRP
143
Global Retirement Partners
California
– -$1K -45 Closed
2 3 4 5
6

ALDR Hedge Fund Activity: Q4 2019 in Review

0 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Alder Biopharmaceuticals (ALDR) for Q4 2019, worth a combined $0 — down 100% from $1.75B a quarter earlier.

Sellers outnumbered buyers: 143 funds closed out of ALDR and 0 opened new positions — a net loss of 143 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Redmile Group, exiting entirely with an estimated $155M sold.

  • 0 institutional investors held Alder Biopharmaceuticals (ALDR) as of Q4 2019, down from 143 in Q3 2019.
  • Funds reported $0 of Alder Biopharmaceuticals stock for Q4 2019, down 100% quarter-over-quarter.
  • 0 funds opened new Alder Biopharmaceuticals positions in Q4 2019 and 143 closed out, a net change of -143 holders.
  • The largest Alder Biopharmaceuticals seller in Q4 2019 was Redmile Group, an estimated $155M sold.

Based on aggregated 13F filings for Q4 2019.